Corbus Pharmaceuticals Holdings, Inc. (CRBP) › Operating IncomeCorbus Pharmaceuticals Holdings, Inc. (CRBP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$557.3K2014: -$2.65M2015: -$8.85M2016: -$19.99M2017: -$32.56M2018: -$56.75M2019: -$77.10M2020: -$122.81M2021: -$55.99M2022: -$39.84M2023: -$45.08M2024: -$48.72M2025: -$85.31M-$85.31M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$85.31M-75.1%2024-$48.72M-8.1%2023-$45.08M-13.2%2022-$39.84M+28.9%2021-$55.99M+54.4%2020-$122.81M-59.3%2019-$77.10M-35.9%2018-$56.75M-74.3%2017-$32.56M-62.9%2016-$19.99M-125.7%2015-$8.85M-234.5%2014-$2.65M-375.0%2013-$557.3K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share